Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 59

Cited In for PubMed (Select 18801868)

1.
2.

Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort.

Naleway AL, Weinmann S, Krishnarajah G, Arondekar B, Fernandez J, Swamy G, Myers E.

PLoS One. 2015 Feb 11;10(2):e0117525. doi: 10.1371/journal.pone.0117525. eCollection 2015.

3.

c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia.

Kübler K, Heinenberg S, Rudlowski C, Keyver-Paik MD, Abramian A, Merkelbach-Bruse S, Büttner R, Kuhn W, Schildhaus HU.

Oncotarget. 2015 Jan 20;6(2):825-35.

4.

Loop electrosurgical excision procedure and risk of vaginal infections during pregnancy: an observational study.

Stout MJ, Frey HA, Tuuli MG, Cahill AG, Odibo AO, Roehl KA, Macones GA.

BJOG. 2015 Mar;122(4):545-51. doi: 10.1111/1471-0528.13252. Epub 2014 Dec 17.

PMID:
25515321
5.

HPV mRNA is more specific than HPV DNA in triage of women with minor cervical lesions.

Sørbye SW, Fismen S, Gutteberg TJ, Mortensen ES, Skjeldestad FE.

PLoS One. 2014 Nov 18;9(11):e112934. doi: 10.1371/journal.pone.0112934. eCollection 2014.

6.

Evaluation of the accuracy in detecting cervical lesions by nurses versus doctors using a stationary colposcope and Gynocular in a low-resource setting.

Nessa A, Roy JS, Chowdhury MA, Khanam Q, Afroz R, Wistrand C, Thuresson M, Thorsell M, Shemer I, Wikström Shemer EA.

BMJ Open. 2014 Nov 3;4(11):e005313. doi: 10.1136/bmjopen-2014-005313.

7.

Fertility and early pregnancy outcomes after treatment for cervical intraepithelial neoplasia: systematic review and meta-analysis.

Kyrgiou M, Mitra A, Arbyn M, Stasinou SM, Martin-Hirsch P, Bennett P, Paraskevaidis E.

BMJ. 2014 Oct 28;349:g6192. doi: 10.1136/bmj.g6192. Review.

8.

An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection.

Bountris P, Haritou M, Pouliakis A, Margari N, Kyrgiou M, Spathis A, Pappas A, Panayiotides I, Paraskevaidis EA, Karakitsos P, Koutsouris DD.

Biomed Res Int. 2014;2014:341483. doi: 10.1155/2014/341483. Epub 2014 Apr 9.

9.

Treatment of cervical precancers: back to basics.

Khan MJ, Smith-McCune KK.

Obstet Gynecol. 2014 Jun;123(6):1339-43. doi: 10.1097/AOG.0000000000000287.

PMID:
24807323
10.

Loop electrosurgical excision procedure and risk of preterm birth: a systematic review and meta-analysis.

Conner SN, Frey HA, Cahill AG, Macones GA, Colditz GA, Tuuli MG.

Obstet Gynecol. 2014 Apr;123(4):752-61. doi: 10.1097/AOG.0000000000000174. Review.

11.

The road ahead for cervical cancer prevention and control.

Tota JE, Ramana-Kumar AV, El-Khatib Z, Franco EL.

Curr Oncol. 2014 Apr;21(2):e255-64. doi: 10.3747/co.21.1720.

12.

Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).

Arbyn M, Fabri V, Temmerman M, Simoens C.

PLoS One. 2014 Apr 1;9(4):e92615. doi: 10.1371/journal.pone.0092615. eCollection 2014.

13.

Current cervical cancer screening knowledge, awareness, and practices among U.S. affiliated pacific island providers: opportunities and challenges.

Townsend JS, Stormo AR, Roland KB, Buenconsejo-Lum L, White S, Saraiya M.

Oncologist. 2014 Apr;19(4):383-93. doi: 10.1634/theoncologist.2013-0340. Epub 2014 Mar 25.

15.

Histology verification demonstrates that biospectroscopy analysis of cervical cytology identifies underlying disease more accurately than conventional screening: removing the confounder of discordance.

Gajjar K, Ahmadzai AA, Valasoulis G, Trevisan J, Founta C, Nasioutziki M, Loufopoulos A, Kyrgiou M, Stasinou SM, Karakitsos P, Paraskevaidis E, Da Gama-Rose B, Martin-Hirsch PL, Martin FL.

PLoS One. 2014 Jan 3;9(1):e82416. doi: 10.1371/journal.pone.0082416. eCollection 2014.

16.

Risk of preterm delivery associated with prior treatment of cervical precancerous lesion according to the depth of the cone.

Berretta R, Gizzo S, Dall'Asta A, Mazzone E, Monica M, Franchi L, Peri F, Patrelli TS, Bacchi Modena A.

Dis Markers. 2013;35(6):721-6. doi: 10.1155/2013/686027. Epub 2013 Nov 13.

17.

Requirement of estrogen receptor alpha DNA-binding domain for HPV oncogene-induced cervical carcinogenesis in mice.

Son J, Park JW, Lambert PF, Chung SH.

Carcinogenesis. 2014 Feb;35(2):489-96. doi: 10.1093/carcin/bgt350. Epub 2013 Oct 22.

18.

Annual Papanicolaou screening for 5 years among human papillomavirus-negative women.

Petry KU, Rinnau F, Böhmer G, Hollwitz B, Luyten A, Buttmann N, Brünger M, Iftner T.

BMC Cancer. 2013 Aug 9;13:379. doi: 10.1186/1471-2407-13-379.

19.

HPV-Based Screening, Triage, Treatment, and Followup Strategies in the Management of Cervical Intraepithelial Neoplasia.

Peralta-Zaragoza O, Deas J, Gómez-Cerón C, García-Suastegui WA, Fierros-Zárate Gdel S, Jacobo-Herrera NJ.

Obstet Gynecol Int. 2013;2013:912780. doi: 10.1155/2013/912780. Epub 2013 Apr 14.

20.

Age-specific occurrence of HPV16- and HPV18-related cervical cancer.

de Sanjose S, Wheeler CM, Quint WG, Hunt WC, Joste NE, Alemany L, Xavier Bosch F; Retrospective International Survey and HPV Time Trends Study Group, Myers ER, Castle PE.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1313-8. doi: 10.1158/1055-9965.EPI-13-0053. Epub 2013 Apr 30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk